Estradiol (E2) and estrogen receptor alpha (ERα) play pivotal roles during ERα-positive breast cancer progression: E2-ERα signaling contributes to cell growth but prevents metastatic potential by preserving the differentiated status of the cells [1-4]. Here, ESR1 is linked to breast carcinoma.